ACTIVE

Dison Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result76,4 k €+6,2 %over 1 year
Gross margin270,5 k €+1,3 %over 1 year
Equity301,7 k €+30,8 %over 1 year
Workforce2,3 ETP+9,5 %over 1 year

Identity

Source · BCE/KBO

Dison Pharma is a Private limited company incorporated in 2015. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Dison. It employs on average 2,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0640.801.992
Incorporation
09/10/2015
Legal form
Private limited company
Registered office
Rue Léopold 58
4820 Dison · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
2,3 ETP
Joint committees (1)
  • 313
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 10 financial years

20252024202320222021
Income statement
Gross margin270,5 k €267 k €234,5 k €232,5 k €216,4 k €
EBITDA149,6 k €140,3 k €154,4 k €147,6 k €145,6 k €
Operating result116,3 k €102,3 k €116 k €110,5 k €103,4 k €
Net result76,4 k €71,9 k €73,1 k €71,3 k €74,1 k €
Balance sheet
Equity301,7 k €230,7 k €179,8 k €144 k €102,4 k €
Total assets638,5 k €629,3 k €592,8 k €672,3 k €651,5 k €
Cash248,7 k €196,9 k €155,8 k €232,2 k €205,2 k €
Debts329,5 k €390,7 k €402,7 k €521,5 k €545,4 k €
Other
Workforce2,3 ETP2,1 ETP1,5 ETP1,7 ETP1,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Olivier RYCKEBUSCH
Directorsince 07/10/2015Manager07/10/2015 → 2016 accountsended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202623/06/202504/07/202401/08/202324/06/202224/06/2021
General meeting15/06/202616/06/202515/06/202415/06/202315/06/202215/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202515/06/202623/06/2026FrenchPDF
Abridged model31/12/202416/06/202523/06/2025FrenchPDF
Abridged model31/12/202315/06/202404/07/2024FrenchPDF
Abridged model31/12/202215/06/202301/08/2023FrenchPDF
Abridged model31/12/202115/06/202224/06/2022FrenchPDF
Abridged model31/12/202015/06/202124/06/2021FrenchPDF
Abridged model31/12/201915/06/202014/07/2020FrenchPDF
Abridged model31/12/201815/06/201918/06/2019FrenchPDF
Micro model31/12/201715/06/201803/07/2018FrenchPDF
Abridged model31/12/201615/06/201728/06/2017FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Olivier RYCKEBUSCH
Directorsince 07/10/2015Manager07/10/2015 → 2016 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/10/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
    PDF
  • Other13/10/2015
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings10 filings
Mandates
Olivier RYCKEBUSCH
201520162017201820192020202120222023202420252026
Dison Pharma
Rue Léopold 58, 4820 Dison
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue Léopold 58, 4820 DisonCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00189075

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Dison PharmaCurrent
accounts 2016 → 2025
Accounts 2025 · 2026-00189075

Events

  1. 2025
    Annual accounts 202576,4 k €↑
  2. 2024
    Annual accounts 202471,9 k €↓
  3. 2023
    Annual accounts 202373,1 k €↑
  4. 2022
    Annual accounts 202271,3 k €↓
  5. 2021
    Annual accounts 202174,1 k €↑
  6. 2020
    Annual accounts 202061 k €↑
  7. 2019
    Annual accounts 201951,4 k €↑
  8. 2018
    Annual accounts 201820 k €↓
  9. 2017
    Annual accounts 201735,6 k €↑
  10. 2016
    Annual accounts 201629 k €
  11. 09/10/2015
    IncorporationPrivate limited company